VanEck Associates
PCYC

VanEck Associates’s PHARMACYCLICS INC PCYC Stock Holding History

VanEck Associates’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-114,558
Closed -$29.3M – 855
2015
Q1 		$29.3M Sell
114,558
-22,899
-17% -$4.42M 0.17% 124
2014
Q4 		$16.8M Sell
137,457
-20,535
-13% -$2.62M 0.1% 152
2014
Q3 		$18.6M Sell
157,992
-2,275
-1% -$259K 0.1% 152
2014
Q2 		$14.4M Buy
160,267
+6,502
+4% +$610K 0.07% 175
2014
Q1 		$15.4M Buy
153,765
+58,629
+62% +$7.62M 0.08% 157
2013
Q4 		$10.1M Sell
95,136
-31,481
-25% -$3.82M 0.05% 183
2013
Q3 		$17.5M Sell
126,617
-10,110
-7% -$1.12M 0.09% 134
2013
Q2 		$10.9M Buy
+136,727
New +$11.2M 0.06% 162

Other funds holding PCYC

Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

VanEck Associates's PCYC Position: Q2 2015 in Review

VanEck Associates sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 114,558 shares — an estimated $29.3M sold.

VanEck Associates first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $29.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • VanEck Associates reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • VanEck Associates sold 114,558 PHARMACYCLICS INC shares in Q2 2015, an estimated $29.3M.
  • VanEck Associates first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • VanEck Associates's PHARMACYCLICS INC position peaked at $29.3M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on VanEck Associates's 13F filing for Q2 2015, filed 12 Aug 2015.